1 / 1

YES

Decision Tree for Inclusion of Minorities In NIH-Defined Phase III Clinical Trials. Is a NIH-Defined Phase III Clinical Trial proposed? . NO. YES. Go To: Decision Tree for Inclusion of Minorities (not an NIH-Defined Phase III Clinical Trial). Is minority representation acceptable?

qiana
Télécharger la présentation

YES

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Decision Tree for Inclusion of Minorities In NIH-Defined Phase III Clinical Trials Is a NIH-Defined Phase III Clinical Trial proposed? NO YES Go To: Decision Tree for Inclusion of Minorities (not an NIH-Defined Phase III Clinical Trial) • Is minority representation acceptable? • 1. Strong evidence exists for significant racial or ethnic differences in intervention effect and study design or analysis can answer primary question(s) separately for each relevant subgroup and the analysis plan can detect significant differences in intervention effect? (Code M1: both U.S. minorities andnon-minorities included)or • 2. Strong evidence exists for NO significant racial or ethnic differences in intervention effect? • (Code M1: both U.S. minorities andnon-minorities, or Code M2: U.S. minorities only, • or Code M3: U.S. non-minorities only)or • 3. No clear evidence exists for or against significant racial or ethnic differences in intervention effect and study design and analysis plans will permit valid analysis of a differential intervention effect? • (Code M1: both U.S. minorities andnon-minorities)or • 4. Some or all minority groups or subgroups are excluded because inclusion is inappropriate with respect to their health or because the research question is not relevant to them? (Code M1: both U.S. minorities andnon-minorities, or Code M2: U.S. minorities only, or Code M3: U.S. non-minorities only)or • 5. ONLY foreign (non-U.S.) subjects are involved and study design addresses any known scientific reasons for examining in-country minority group or subgroup differences (Code M5: no U.S. subjects involved) YES ABSENT No Information NO ACCEPTABLE M1A, M2A, M3A, M4A, or M5A Describe: inclusion plan, any exclusions of minority subpopulations, plans for analysis and outreach. State why this is scientifically acceptable. UNACCEPTABLE M1U, M2U, M3U, M4U, or M5U Negative impact on score. Describe: inclusion plan, any exclusions of minority subpopulations, plans for analysis and outreach. State why this is scientifically unacceptable. UNACCEPTABLE Contact Scientific Review Administrator Summary of Codes Representation is scientifically… Minority Representation Acceptable Unacceptable Both minorities and non-minorities included M1A M1U Minorities only M2A M2U Non-minorities only M3A M3U Unknown (cannot be known) M4A M4U ONLY foreign (non-U.S.) subjects in study M5A M5U NIH/OER April 26, 2001

More Related